Identification of the RP11-21C4.1/SVEP1 gene pair associated with FAT2 mutations as a potential biomarker in gastric cancer

References

• Jim MA, Pinheiro PS, Carreira H, et al. Stomach cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123(Suppl 24):4994–5013.
   PubMedGoogle Scholar
• Salati M, Orsi G, Smyth E, et al. Gastric cancer: translating novels concepts into clinical practice. Cancer Treat Rev. 2019;79:101889.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Yang SR, Schultheis AM, Yu H, et al. Precision medicine in non-small cell lung cancer: current applications and future directions. Semin Cancer Biol. 2020. in-print.
   Web of Science ®Google Scholar
• Bailey AM, Mao Y, Zeng J, et al. Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps. Discov Med. 2014;17(92):101–114.
   PubMed Web of Science ®Google Scholar
• Katoh M. Function and cancer genomics of FAT family genes (review). Int J Oncol. 2012;41(6):1913–1918.
   PubMed Web of Science ®Google Scholar
• Tate G, Kishimoto K, Mitsuya T. A novel mutation of the FAT2 gene in spinal meningioma. Oncol Lett. 2016;12(5):3393–3396.
   PubMed Web of Science ®Google Scholar
• Miyanaga A, Masuda M, Tsuta K, et al. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol. 2015;10(5):844–851.
   PubMed Web of Science ®Google Scholar
• Gao YB, Chen ZL, Li JG, et al. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet. 2014;46(10):1097–1102.
   PubMed Web of Science ®Google Scholar
• Xie T, Cho YB, Wang K, et al. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing. Genomics. 2014;104(4):234–241.
   PubMed Web of Science ®Google Scholar
• Matsui S, Utani A, Takahashi K, et al. Knockdown of Fat2 by siRNA inhibits the migration of human squamous carcinoma cells. J Dermatol Sci. 2008;51(3):207–210.
   PubMed Web of Science ®Google Scholar
• Dang TT, Westcott JM, Maine EA, et al. ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion. Oncotarget. 2016;7(19):28592–28611.
   PubMedGoogle Scholar
• Li L, Fu LQ, Wang HJ, et al. FAT2 is a novel independent prognostic factor for the poor prognosis of gastric carcinoma. Int J Clin Exp Pathol. 2017;10(12):11603–11609.
   PubMed Web of Science ®Google Scholar
• Kristensen VN, Lingjærde OC, Russnes HG, et al. Principles and methods of integrative genomic analyses in cancer. Nat Rev Cancer. 2014;14(5):299–313.
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29(4):452–463.
   PubMed Web of Science ®Google Scholar
• Zhang SY, Zhang SQ, Nagaraju GP, et al. Biomarkers for personalized medicine in GI cancers. Mol Aspects Med. 2015;45:14–27.
   PubMed Web of Science ®Google Scholar
• Yang KS, Orcid I, Xu CQ, et al. Identification and validation of the prognostic value of cyclic GMP-AMP. Bioengineered. 2021;12(1):1238–1250.
   PubMed Web of Science ®Google Scholar
• Ng PK, Li J, Jeong KJ, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33(3):450–462.e10.
   PubMed Web of Science ®Google Scholar
• Takiar V, Ip CK, Gao M, et al. Neomorphic mutations create therapeutic challenges in cancer. Oncogene. 2017;36(12):1607–1618.
   PubMed Web of Science ®Google Scholar
• Cho E, Feng Y, Rauskolb C, et al. Delineation of a Fat tumor suppressor pathway. Nat Genet. 2006;38(10):1142–1150.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Li T, Zheng S, et al. The Hippo pathway as a drug target in gastric cancer. Cancer Lett. 2018;420:14–25.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253–1261.
   PubMed Web of Science ®Google Scholar
• Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719.
   PubMed Web of Science ®Google Scholar
• Fan CN, Ma L, Liu N. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer. J Cell Biochem. 2019;120(3):3185–3196.
   PubMed Web of Science ®Google Scholar
• Liu J, Yao Y, Hu Z, et al. Transcriptional profiling of long-intergenic noncoding RNAs in lung squamous cell carcinoma and its value in diagnosis and prognosis. Mol Genet Genomic Med. 2019;7(12):e994.
   PubMed Web of Science ®Google Scholar
• Li Y, Cao X, Li H. Identification and Validation of Novel Long Non-coding RNA Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma. Front Bioeng Biotechnol. 2020;8:256.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352.
   PubMed Web of Science ®Google Scholar
• Bajo-Grañeras R, Crespo-Sanjuan J, García-Centeno RM, et al. Expression and potential role of apolipoprotein D on the death-survival balance of human colorectal cancer cells under oxidative stress conditions. Int J Colorectal Dis. 2013;28(6):751–766.
   PubMed Web of Science ®Google Scholar
• Jankovic-Karasoulos T, Bianco-Miotto T, Butler MS, et al. Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients. Histopathology. 2020;76(7):976–987.
   PubMed Web of Science ®Google Scholar
• Hu C, Zhou Y, Liu C, et al. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes. Int J Oncol. 2018;53(2):633–643.
   PubMed Web of Science ®Google Scholar
• Ma F, Xie Y, Lei Y, et al. The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer. BMC Cancer. 2020;20(1):580.
   PubMed Web of Science ®Google Scholar
• Yan H, Zheng C, Li Z, et al. NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer. Cancer Manag Res. 2019;11:3237–3251.
   PubMed Web of Science ®Google Scholar
• Sigova AA, Mullen AC, Molinie B, et al. Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci U S A. 2013;110(8):2876–2881.
   PubMed Web of Science ®Google Scholar
• Luo S, Lu JY, Liu L, et al. Divergent lncRNAs Regulate Gene Expression and Lineage Differentiation in Pluripotent Cells. Cell Stem Cell. 2016;18(5):637–652.
   PubMed Web of Science ®Google Scholar
• Hu X, Yang L, Mo YY. Role of Pseudogenes in Tumorigenesis. Cancers (Basel). 2018;10(8):256.
   PubMed Web of Science ®Google Scholar
• Wang J, Huang F, Shi Y, et al. RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription. Gastric Cancer. 2020;24(1):85–102.
   PubMed Web of Science ®Google Scholar
• Chen L, Liu D, Yi X, et al. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway. Cell Death Dis. 2020;11(5):320.
   PubMed Web of Science ®Google Scholar